Further Evidence for the Implication of the MET Gene in Non-Syndromic Autosomal Recessive Deafness

Hum Hered. 2019;84(3):109-116. doi: 10.1159/000503450. Epub 2019 Dec 4.

Abstract

Mutations in the mesenchymal epithelial transition factor (MET) gene are frequently associated with multiple human cancers but can also lead to human non-syndromic autosomal recessive deafness (DFNB97). In the present study, we identified a novel homozygous missense mutation in the METgene causing a non-syndromic hearing impairment DFNB97 form. Whole-exome sequencing was performed to determine the genetic causes of hearing loss in a Moroccan consanguineous family with an affected daughter. The structural analysis of native and mutant in the SEMA domain of the MET receptor was investigated using a molecular dynamics simulation (MDS) approach. We identified a novel pathogenic homozygous c.948A>G (p.Ile316Met) mutation in the MET gene in one deaf Moroccan young girl carrying a total bilateral non-syndromic hearing impairment. The results of the MDS approach show that an Ile316Met mutation in the SEMA domain leads to protein flexibility loss. This may produce a major impact on the structural conformation of the MET receptor, which also affects the function and binding site of the receptor. This is the first time that a mutation in the MET gene is described in a Moroccan family. Moreover, this study reports the second family in the world associating deafness and mutation in the MET gene.

Keywords: HGFR gene; Hearing loss; MET gene; Moroccan family; Mutation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Consanguinity
  • Female
  • Hearing Loss, Sensorineural / genetics*
  • Humans
  • Molecular Dynamics Simulation
  • Mutation, Missense
  • Pedigree
  • Proto-Oncogene Proteins c-met / genetics*
  • Whole Genome Sequencing

Substances

  • Proto-Oncogene Proteins c-met

Supplementary concepts

  • Deafness, Autosomal Recessive